1269260-01-6 Usage
Uses
Used in Pharmaceutical Industry:
3-Pyrrolidinecarboxylic acid, 4-(4-methoxyphenyl)-, methyl ester, (3S,4R)is used as a chiral building block for the synthesis of various pharmaceutical drugs and biologically active molecules. Its unique stereochemistry allows for the creation of enantiomerically pure compounds, which is crucial for the development of effective and safe medications.
Used in Organic Chemical Synthesis:
In the field of organic chemistry, 3-Pyrrolidinecarboxylic acid, 4-(4-methoxyphenyl)-, methyl ester, (3S,4R)serves as a valuable reagent for the preparation of various organic compounds. Its versatile structure and functional groups enable chemists to perform a range of reactions, leading to the formation of new molecules with potential applications in various industries.
Used in Medicinal Chemistry Research:
3-Pyrrolidinecarboxylic acid, 4-(4-methoxyphenyl)-, methyl ester, (3S,4R)is being studied for its pharmacological activities, as it possesses potential medicinal properties. Researchers are exploring its interactions with biological targets and evaluating its efficacy in treating various diseases and conditions. 3-Pyrrolidinecarboxylic acid, 4-(4-methoxyphenyl)-, methyl ester, (3S,4R)-'s unique structure and chirality make it an interesting candidate for drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1269260-01-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,9,2,6 and 0 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1269260-01:
(9*1)+(8*2)+(7*6)+(6*9)+(5*2)+(4*6)+(3*0)+(2*0)+(1*1)=156
156 % 10 = 6
So 1269260-01-6 is a valid CAS Registry Number.
1269260-01-6Relevant articles and documents
HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6
-
Paragraph 00399; 00415, (2021/09/04)
The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.
Design and syntheses of melanocortin subtype-4 receptor agonists. Part 2: Discovery of the dihydropyridazinone motif
Ujjainwalla, Feroze,Warner, Daniel,Snedden, Christine,Grisson, Ricky D.,Walsh, Thomas F.,Wyvratt, Matthew J.,Kalyani, Rubana N.,MacNeil, Tanya,Tang, Rui,Weinberg, David H.,Van Der Ploeg, Lex,Goulet, Mark T.
, p. 4023 - 4028 (2007/10/03)
Optimization of the biological activity of a new class of non-peptidyl, pyridazinone derived human melanocortin subtype-4 receptor agonists is disclosed.
